EnVVeno Medical Corporation EnVVeno Medical Corporation

EnVVeno Medical Corporation

NVNO

Pozycja w akcjach #40246
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Cena akcji
$10.71
Ostatnia synchronizacja: 2026-07-31
Kapitalizacja rynkowa
$176.75K
Zmiana (1 dzień)
0.79%
Zmiana (1 rok)
169,900.00%
Kraj
US
Handel EnVVeno Medical Corporation (NVNO)

Kategoria

Healthcare
Historia dywidend dla EnVVeno Medical Corporation (NVNO)
EnVVeno Medical Corporation (symbol giełdowy: NVNO) wypłaciła łącznie 0 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Wypłaty dywidend dla EnVVeno Medical Corporation (NVNO) od 2026 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
Za mało danych dla podanych dat.
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
Za mało danych dla podanych dat.
Wypłaty dywidend firm podobnych lub konkurencyjnych
Firma Liczba wypłat dywidend Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00%
DE